164 related articles for article (PubMed ID: 2438930)
1. Immunohistochemical characterization of renal amyloidosis.
Noel LH; Droz D; Ganeval D
Am J Clin Pathol; 1987 Jun; 87(6):756-61. PubMed ID: 2438930
[TBL] [Abstract][Full Text] [Related]
2. Typing of amyloidosis in renal biopsies: diagnostic pitfalls.
Satoskar AA; Burdge K; Cowden DJ; Nadasdy GM; Hebert LA; Nadasdy T
Arch Pathol Lab Med; 2007 Jun; 131(6):917-22. PubMed ID: 17550319
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of different pathological staining methods for classifying renal amyloidosis].
Zhou Z; Cao W
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1448-52. PubMed ID: 24144744
[TBL] [Abstract][Full Text] [Related]
4. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
Paueksakon P; Fogo AB; Sethi S
Hum Pathol; 2014 Jul; 45(7):1445-50. PubMed ID: 24792621
[TBL] [Abstract][Full Text] [Related]
6. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
van Rijswijk MH; van Heusden CW
Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
[TBL] [Abstract][Full Text] [Related]
7. A Novel Method of DAPI Staining for Differential Diagnosis of Renal Amyloidosis.
Matsuura M; Abe H; Tominaga T; Sakurai A; Murakami T; Kishi S; Bando Y; Minakuchi J; Nagai K; Doi T
J Med Invest; 2017; 64(3.4):217-221. PubMed ID: 28954985
[TBL] [Abstract][Full Text] [Related]
8. Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.
Bély M; Apáthy A
Amyloid; 2000 Sep; 7(3):212-7. PubMed ID: 11019862
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and origin of amyloid in kidney biopsies.
von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
[TBL] [Abstract][Full Text] [Related]
10. Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence.
Collins AB; Smith RN; Stone JR
Cardiovasc Pathol; 2009; 18(4):205-16. PubMed ID: 18619857
[TBL] [Abstract][Full Text] [Related]
11. Methods for staining amyloid in tissues: a review.
Elghetany MT; Saleem A
Stain Technol; 1988 Jul; 63(4):201-12. PubMed ID: 2464206
[TBL] [Abstract][Full Text] [Related]
12. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
[TBL] [Abstract][Full Text] [Related]
13. Abdominal fat tissue aspirate in human amyloidosis: light, electron, and immunofluorescence microscopic studies.
Orfila C; Giraud P; Modesto A; Suc JM
Hum Pathol; 1986 Apr; 17(4):366-9. PubMed ID: 2420696
[TBL] [Abstract][Full Text] [Related]
14. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.
Janssen S; Elema JD; van Rijswijk MH; Limburg PC; Meijer S; Mandema E
Appl Pathol; 1985; 3(1-2):29-38. PubMed ID: 3915945
[TBL] [Abstract][Full Text] [Related]
15. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
Sjölander D; Röcken C; Westermark P; Westermark GT; Nilsson KP; Hammarström P
Amyloid; 2016 Jun; 23(2):98-108. PubMed ID: 26987044
[TBL] [Abstract][Full Text] [Related]
16. Analysis of clinical and pathological characteristics of 28 cases with renal amyloidosis.
Zhu X; Liu F; Liu Y; Liu H; Xu X; Peng Y; Sun L; Yuan S
Clin Lab; 2011; 57(11-12):947-52. PubMed ID: 22239026
[TBL] [Abstract][Full Text] [Related]
17. Characterization of tissue amyloid by immunofluorescence microscopy.
Gallo GR; Feiner HD; Chuba JV; Beneck D; Marion P; Cohen DH
Clin Immunol Immunopathol; 1986 Jun; 39(3):479-90. PubMed ID: 3084146
[TBL] [Abstract][Full Text] [Related]
18. New insights into systemic amyloidosis: the importance of diagnosis of specific type.
Picken MM
Curr Opin Nephrol Hypertens; 2007 May; 16(3):196-203. PubMed ID: 17420662
[TBL] [Abstract][Full Text] [Related]
19. Immunofluorescence study of childhood renal amyloidosis.
Tinaztepe K; Güçer KS
Turk J Pediatr; 1992; 34(1):5-14. PubMed ID: 1509531
[TBL] [Abstract][Full Text] [Related]
20. A proposed histopathologic classification, scoring, and grading system for renal amyloidosis: standardization of renal amyloid biopsy report.
Sen S; Sarsik B
Arch Pathol Lab Med; 2010 Apr; 134(4):532-44. PubMed ID: 20367305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
